{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:10:47Z","timestamp":1771647047295,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0170, L3-8203 and L3-2622"],"award-info":[{"award-number":["P1-0170, L3-8203 and L3-2622"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Metalloproteinases (MMPs) have an important role in tissue remodeling and have been shown to have an effect on tumor progression, invasion, metastasis formation, and apoptosis in several tumors, including mesothelioma. Mesothelioma is a rare tumor arising from pleura and peritoneum and is frequently associated with asbestos exposure. We have performed a systematic search of PubMed.gov and ClinicalTrials.gov databases to retrieve and review three groups of studies: studies of MMPs expression in tumor tissue or body fluids in patients with mesothelioma, studies of MMPs genetic variability, and studies of MMPs as potential novel drug targets in mesothelioma. Several studies of MMPs in mesothelioma tissues reported a link between higher expression levels of commonly studied MMPs and clinical parameters, such as overall survival. Fewer studies have investigated genetic variability of MMP genes. Nevertheless, these studies suggested that certain genetic variants in MMP genes can have either protective or tumor-promoting effects on mesothelioma patients. MMPs have been also reported as novel drug targets, but so far no clinical trials of MMP inhibitors are registered in mesothelioma. In conclusion, MMPs play an important role in mesothelioma, but further studies are needed to elucidate the potentials of MMPs as biomarkers and drug targets in mesothelioma.<\/jats:p>","DOI":"10.3390\/biom11091272","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:19:26Z","timestamp":1629937166000},"page":"1272","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review"],"prefix":"10.3390","volume":"11","author":[{"given":"Danijela","family":"\u0160trbac","sequence":"first","affiliation":[{"name":"Institute of Oncology, Zalo\u0161ka 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-6649","authenticated-orcid":false,"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[{"name":"Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020, September 20). Global Mesothelioma Deaths Reported to the World Health Organization between 1994 and 2008. Available online: https:\/\/www.who.int\/bulletin\/volumes\/89\/10\/11-086678\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00420-019-01433-4","article-title":"Risk of mesothelioma after cessation of asbestos exposure: A systematic review and meta-regression","volume":"92","author":"Boffetta","year":"2019","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: Global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.6004\/jnccn.2016.0087","article-title":"NCCN guidelines insights: Malignant pleural mesothelioma, Version 3.2016","volume":"14","author":"Ettinger","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.thorsurg.2020.08.001","article-title":"Mesothelioma biomarkers: Discovery in search of validation","volume":"30","author":"Pass","year":"2020","journal-title":"Thorac. Surg. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.21873\/cgp.20183","article-title":"Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell secretome","volume":"17","author":"Lacerenza","year":"2020","journal-title":"Cancer Genom. Proteom."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: Regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Ewald","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Series \u201cMatrix metalloproteinases in lung health and disease\u201d: Biological role of matrix metalloproteinases: A critical balance","volume":"38","author":"Schilling","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000468613","article-title":"MMP-2: Expression, activation and inhibition","volume":"49","author":"Corcoran","year":"1996","journal-title":"Enzym. Protein"},{"key":"ref_13","unstructured":"(2021, July 25). Pubmed.gov, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/."},{"key":"ref_14","unstructured":"(2021, July 25). Clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumor-associated markers for early detection of malignant mesothelioma: An epidemiologic study","volume":"17","author":"Amati","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_16","first-page":"335","article-title":"Biomarkers for prevention and early diagnosis of malignant pleural mesothelioma","volume":"29","author":"Amati","year":"2007","journal-title":"G. Ital. Di Med. Del Lav. Ed Ergon."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","article-title":"Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura","volume":"88","author":"Edwards","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16678","DOI":"10.1038\/s41598-020-72448-y","article-title":"Proteasomal degradation of polycomb-group protein CBX6 Confers MMP-2 expression essential for mesothelioma invasion","volume":"10","author":"Sakai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_19","first-page":"1283","article-title":"Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines","volume":"22","author":"Roomi","year":"2009","journal-title":"Oncol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexmp.2010.10.008","article-title":"MT1-MMP plays an important role in an invasive activity of malignant pleural mesothelioma cell","volume":"90","author":"Doi","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/1078-0432.CCR-11-2614","article-title":"Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients","volume":"18","author":"Servais","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41598-018-36560-4","article-title":"CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Crispi, S., Calogero, R.A., Santini, M., Mellone, P., Vincenzi, B., Citro, G., Vicidomini, G., Fasano, S., Meccariello, R., and Cobellis, G. (2009). Global gene expression profiling of human pleural mesotheliomas: Identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007016"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.20605","article-title":"ERK1\/2 and P38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: A comparison between mesothelioma and mesothelial cells","volume":"207","author":"Zhong","year":"2006","journal-title":"J. Cell Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2478\/raon-2018-0005","article-title":"Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma","volume":"52","author":"Strbac","year":"2018","journal-title":"Radiol. Oncol."},{"key":"ref_26","first-page":"8069529","article-title":"Matrix metalloproteinases polymorphisms as prognostic biomarkers in malignant pleural mesothelioma","volume":"2017","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_27","first-page":"1242964","article-title":"Evaluation of matrix metalloproteinase 9 serum concentration as a biomarker in malignant mesothelioma","volume":"2019","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1016\/j.jtho.2016.11.302","article-title":"OA13.03 long-term overall survival for patients with malignant pleural mesothelioma on pembrolizumab enrolled in KEYNOTE-028","volume":"12","author":"Alley","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Matejczyk","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/01902140600710488","article-title":"Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture","volume":"32","author":"Roomi","year":"2006","journal-title":"Exp. Lung. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19273","DOI":"10.18632\/oncotarget.25018","article-title":"Antitumor efficacy of kisspeptin in human malignant mesothelioma cells","volume":"9","author":"Ciaramella","year":"2018","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2184.2010.00663.x","article-title":"3-O-methylfunicone, a metabolite produced by penicillium pinophilum, modulates ERK1\/2 activity, affecting cell motility of human mesothelioma cells","volume":"43","author":"Buommino","year":"2010","journal-title":"Cell Prolif."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/ar604","article-title":"Drugs in development: Bisphosphonates and metalloproteinase inhibitors","volume":"5","author":"Catterall","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1158\/1078-0432.CCR-05-2766","article-title":"Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo","volume":"12","author":"Wakchoure","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-018-3483-9","article-title":"IL-17A\/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via P38 MAPK signaling pathway in non-small cell lung cancer","volume":"455","author":"Wu","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ijc.24441","article-title":"Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects","volume":"125","author":"McColgan","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Arriaga, P., Pascual, T., Garc\u00eda-Alvarez, A., Fern\u00e1ndez-Somoano, A., L\u00f3pez-Cima, M.F., and Tard\u00f3n, A. (2012). Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-121"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/LBR.0000000000000094","article-title":"Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum Mmp-9 activity, pathologic type, and prognosis","volume":"21","author":"Yousef","year":"2014","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1183\/09031936.00125608","article-title":"Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis","volume":"35","author":"Scherf","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jss.2013.01.045","article-title":"The relationship of metalloproteinase gene polymorphisms and lung cancer","volume":"183","author":"Sanli","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chimed-Ochir, O., Arachi, D., Driscoll, T., Lin, R.-T., Takala, J., and Takahashi, K. (2020). Burden of mesothelioma deaths by national income category: Current status and future implications. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17186900"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/9\/1272\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:51:34Z","timestamp":1760165494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/9\/1272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["biom11091272"],"URL":"https:\/\/doi.org\/10.3390\/biom11091272","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}